Here's what the latest FOMC decision at the Fed means for the big banks on Wall Street and why that matters to investors and ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...

Topline Results for Phase 2b PROGRESS Study of Pilavapadin (LX9211) in Diabetic Peripheral Neuropathic Pain (DPNP); 10 mg dose to Advance into ...

Wu, J.J. and Liang, G.H. (2025) Progress in Diagnosis and Treatment of Fungal Keratitiss. Journal of Biosciences and Medicines, 13, 138-146. doi: 10.4236/jbm.2025.133011 .

PYZCHIVA becomes Samsung Bioepis’ fifth biosimilar and third immunology biosimilar to be launched in the US Commercialized by Sandoz, PYZCHIVA offers three different strengths Samsung Bioepis Co ...

PYZCHIVA becomes Samsung Bioepis’ fifth biosimilar and third immunology biosimilar to be launched in the US Commercialized by Sandoz, PYZCHIVA offers three different strengths INCHEON, ...